39hospital.com
39 Hospital is an internet hospital platform serving urban and county hospitals and discipline centers.
| Date | Investors | Amount | Round |
|---|---|---|---|
$7.5m | Angel | ||
| Total Funding | 000k | ||
Guiyang Sanjiu Internet Hospital Co., Ltd., operating as 39hospital.com, is a remote medical consultation platform in China, established on February 18, 2016. The company was founded by Guiyang Langma Information Technology Co., Ltd. (Langma Information), with Wang Wei serving as the chairman and Pang Chenglin as the general manager. Pang Chenglin previously held the position of marketing director at Pfizer China. The company's business model is centered around connecting patients and primary care physicians in county-level and urban hospitals with top medical experts for remote consultations, particularly for difficult and severe cases. This service aims to facilitate a tiered diagnosis and treatment system, improving the quality of care in基层 (jīcéng - grassroots/local) hospitals.
39hospital.com provides a comprehensive remote healthcare solution, including services like remote expert consultations, remote ward rounds, and training for local doctors. The platform leverages its proprietary audio-video systems, electronic medical records, and remote imaging systems to create a closed-loop medical service from screening and diagnosis to treatment and follow-up. It operates on a B2B2C model, primarily collaborating with city and county hospitals to enhance their specialty departments. By the end of 2022, the company had partnered with over 1,300 hospitals and had more than 2,000 contracted medical experts, including renowned specialists like Guo Yinglu and Huo Yong. Revenue is likely generated through service fees for these remote medical services, paid by either the hospitals or the patients.
The company's establishment was part of a broader trend of integrating internet technology with healthcare in China. It received an angel investment of 50 million RMB in July 2016 from investors including IDG Capital, Guiyang Ventures, and Langma Information. This was followed by subsequent equity financing rounds in 2018 and 2019. The platform serves a critical need in the Chinese healthcare market by making top-tier medical expertise accessible to patients in remote or underserved areas, thereby reducing the need for travel and associated costs. As of late 2022, the platform had over one million registered users and had conducted more than 500,000 medical services across 27 provinces.
Keywords: remote healthcare, telemedicine, medical consultation, healthcare platform, digital health, tiered healthcare, medical expertise, remote diagnosis, specialty care, China healthcare